Angion Biomedica is a clinical-stage organ restoration biopharmaceutical company focused on renal disease including acute kidney injury and chronic renal disease.
We are pioneers in using rational drug design to target the body’s protective, reparative and regenerative system for therapeutic benefit. We believe these treatment objectives address significant unmet need in both orphan indications and large clinical landscapes.
Our fully integrated multidisciplinary research and development facility is located in Uniondale, NY. This state-of-the-art facility accommodates rational drug discovery, development and clinical operations.